Professional Documents
Culture Documents
Mazor Robotics Corporate - Presentation - March 2018
Mazor Robotics Corporate - Presentation - March 2018
March, 2018
1
FORWARD LOOKING STATEMENT
This presentation contains “forward-looking statements” within the meaning of the Private Securities Litigation
Reform Act of 1995 and other securities laws. Forward-looking statements are not historical facts, and are based
upon management’s current expectations, beliefs and projections, many of which, by their nature, are inherently
uncertain. Such expectations, beliefs and projections are expressed in good faith. However, there can be no
assurance that management’s expectations, beliefs and projections will be achieved and actual results may differ
materially from what is expressed in or indicated by the forward-looking statements. Forward-looking statements are
subject to risks and uncertainties that could cause actual performance or results to differ materially from those
expressed in the forward-looking statements, including risks detailed in Mazor Robotics Ltd.’s (“Mazor Robotics” or
the “Company”) annual reports on Form 20-F filed with the U.S. Securities and Exchange Commission. The following
solutions are not yet cleared for use: Navigation, Guidewireless
Forward-looking statements speak only as of the date the statements are made. The Company assumes no
obligation to update forward-looking statements to reflect actual results, subsequent events or circumstances,
changes in assumptions or changes in other factors affecting forward-looking information except to the extent
required by applicable securities laws. If the Company does update one or more forward-looking statements, no
inference should be drawn that the Company will make additional updates with respect thereto or with respect to
other forward-looking statements.
mazorrobotics.com 2
Healing through Innovation
Strategic Vision
• Growth through continued market leadership and focus on partnership with Medtronic
• Evidence Based Medicine with predictability and efficiency for the healthcare community
• Strategic and Economic Value through innovative products and procedural solutions for our
partners
• Innovation for safer and predictable surgery with clinically-evidenced outcomes for patients
mazorrobotics.com 3
Current Snapshot
From Vision to Experienced Market Leader
mazorrobotics.com 4
Mazor Robotic Guidance Systems
Predictability, Precision and Efficiency through Innovation
mazorrobotics.com 5
Mazor Core
Surgical Planning Suite Anatomy Recognition Engine Patient Connection Platform Cross-modality image registration
• 3D analytics and virtual tools • The advanced anatomy recognition • Set of biocompatible devices that rigidly • Sophisticated registration tool with the
developed to determine procedure engine reads images and recognizes affix the robotic system/arm to the ability to analyze and match images from
goals and surgical plan. The suite of anatomical features based on advanced patient’s skeletal anatomy during surgery, different modalities and body positions,
tools allow creation of a “surgical and proprietry algorithms. ensuring precision through a stable, solid e.g. pre-op CT with intra-op fluoroscopy.
blueprint” that separates the
connection.
surgeon’s analytical planning • The engine is fundamental for planning
process from the actual surgery. • Each vertebra is registered independently
and serves as the underlying technology • This unique feature maintains patient- of the others and irrespective of
for features such as vertebral machine unity during the operation and modality, date of the image, or patient
• During surgery, the surgeon
executes the plan as an efficient and segmentation, image registration and is a major contributor to accuracy. position.
predictable procedure with no alignment calculations.
anatomical surprises. Implants are
pre-selected and prepped, the team
knows what to expect.
mazorrobotics.com 6
Installed Base (Q4/2017)
> 180 Systems Worldwide
. .. . .. ... .....
.. . ...
.
. . . .. . ......
.
.. . .. Q3/17 Mazor X CE Approval
Trigger for first global
expansion of Mazor X
mazorrobotics.com 7
Commercial Success
Launch and Adoption of Mazor X
150 6 72
100
143
50 108 116
83
63
27 41
0 18
Consistent Accuracy with Improved Outcomes Proven Reduction in Complications and Revisions (1)
18.1%
5.2% 5.8%
0.9%
1 2
Dr. Thomas Sweeney,, Orthopaedic Surgeon, FL Proven Reduction in Exposure to Radiation (2)
Caveats:
• Interim report – only 92 control patients
• Only 2 surgeons in control arm
• 6-month average follow-up
• High event rate in fluoro-guided arm
mazorrobotics.com 11
How could Mazor Core impact health economics?
• If a surgeon changes 100 Fluoro-guided MIS cases to Mazor Core MIS per year:
Event
Eventtype
type Baseline
Baseline number of
number Relative
Relative Risk* Anticipated
Anticipated number of Reduction
Reduction in number
in Cost
Costofofevent** Reduced
Reduced costs
costs
events* events* of events*
of events* Risk* number of number of event**
events* events*
Complications
Complications 27
27 5.3
5.3 55 22
22 $9K
$9K $200K
$198K
Revisions
Revisions 44 7.1
7.1 11 33 $28K
$28K $84K
$84K
mazorrobotics.com 12
Updated Business Model
Three Sources
mazorrobotics.com 13
Renaissance
New Business Model
• Technology
• Mazor Core + Brain
• 10% of accounts include Renaissance Brain
• Business Model:
• Geographic areas where Mazor X regulatory clearance is not imminent
• Target Market: Medicare accredited ASCs in the United States
• International
• Global Sales Organization
• Active distributors in China, Taiwan, Australia, Thailand, Vietnam, Germany
• Pipeline
• Simplified workflow to fit single level procedure
mazorrobotics.com 14
Revenue Breakdown
Year Ended December, 2017
$70,000
$64,947
Disposables, Service and Others
$60,000
Systems
$50,000 43%
$40,000
$36,379
$30,000
$26,096 46%
$19,983 $21,208
$20,000 49% 57%
$12,175 32% 43%
$10,000 $5,904 29% 54%
$3,973 68% 57% 51%
26% 30%
70% 71%
$0 74%
Gross margin 76% 68% 76% 79% 79% 78% 72% 64%
mazorrobotics.com 15
Income Statement
Income Statement
Operating Expenses
Research and development, net $8,192 $5,736
Selling and marketing, net $39,499 $33,637
General and administrative $7,375 $5,697
Total operating expenses $55,066 $45,070
% of revenue 85% 124%